Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Orally administered dextran sulfate is absorbed in HIV-positive individuals.

Hiebert LM, Wice SM, Jaques LB, Williams KE, Conly JM.

J Lab Clin Med. 1999 Feb;133(2):161-70.

PMID:
9989768
2.

Antithrombotic activity of oral unfractionated heparin.

Hiebert LM, Wice SM, Jaques LB.

J Cardiovasc Pharmacol. 1996 Jul;28(1):26-9.

PMID:
8797132
3.

The heparin target organ--the endothelium. Studies in a rat model.

Hiebert LM, Wice SM, McDuffie NM, Jaques LB.

Q J Med. 1993 May;86(5):341-8.

PMID:
8327652
4.

Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000.

Jaques LB, Hiebert LM, Wice SM.

J Lab Clin Med. 1991 Feb;117(2):122-30.

PMID:
1993853
5.

Glycosaminoglycans as polyelectrolytes: rejuvenation of original concepts.

Jaques LB.

Semin Thromb Hemost. 1991;17 Suppl 1:1-4. Review. No abstract available.

PMID:
2068561
6.

Determination of absolute amounts of heparin and of dextran sulfate in plasma in microgram quantities.

Jaques LB, Wice SM, Hiebert LM.

J Lab Clin Med. 1990 Apr;115(4):422-32.

PMID:
1691256
7.

The close relationship of heparin and the vessel wall.

Jaques LB, Hiebert LM.

Artery. 1989;16(3):140-50.

PMID:
2730347
8.

The Howell theory of blood coagulation: a record of the pernicious effects of a false theory.

Jaques LB.

Can Bull Med Hist. 1988 Winter;5(2):143-65. No abstract available.

PMID:
11621891
9.

Bleeding and hemostasis.

Jaques LB.

J Can Dent Assoc. 1987 Aug;53(8):627-32. No abstract available.

PMID:
3308025
10.

Drug prophylaxis in atherosclerosis.

Jaques LB.

Artery. 1987;14(4):209-15.

PMID:
2441684
11.

The new understanding of the drug heparin.

Jaques LB.

Chest. 1985 Nov;88(5):751-4. No abstract available.

PMID:
2414075
12.

Lipid metabolism: the histamine-glycosaminoglycan-histaminase connection.

Mahadoo J, Jaques LB, Wright CJ.

Med Hypotheses. 1981 Aug;7(8):1029-38. No abstract available.

PMID:
6793818
13.

Effect of intrapulmonary heparin on plasma diamine oxidase (histaminase) activity in mice.

Mahadoo J, Wright CJ, Jaques LB.

Agents Actions. 1981 Jul;11(4):335-8.

PMID:
6792876
14.

Reversal of protamine of the prolonged response to intrapulmonary heparin.

Wright CJ, Mahadoo J, Jaques LB.

Can J Surg. 1981 Mar;24(2):130-2.

PMID:
7225967
15.

Effect of intrapulmonary heparin on lipoprotein lipase activity in mice.

Mahadoo J, Wright CJ, Jaques LB.

Atherosclerosis. 1981 Jan-Feb;38(1-2):197-202.

PMID:
7470199
16.

Effects of long-term treatment of mice with intrapulmonary heparin.

Mahadoo J, Hines JG, Jaques LB.

Arzneimittelforschung. 1981;31(6):976-8.

PMID:
7196244
17.

Vascular distribution of intratracheally administered heparin.

Mahadoo J, Hiebert LM, Wright CJ, Jaques LB.

Ann N Y Acad Sci. 1981;370:650-5. Review. No abstract available.

PMID:
7023328
18.

The hemostasis paradigm in 1934 and in 1980.

Jaques LB.

Ann N Y Acad Sci. 1981;370:1-4. No abstract available.

PMID:
7023316
19.

Ultra-low-dose heparin.

Jaques LB, Hiebert LM, Mahadoo J, Wright CJ.

Lancet. 1980 Dec 20-27;2(8208-8209):1369. No abstract available.

PMID:
6109181
20.

Standardization of heparin.

Jaques LB.

Thromb Haemost. 1980 Jul 15;43(3):228. No abstract available.

PMID:
7455988
21.
22.

Endothelial sequestration of heparin administered by the intrapulmonary route.

Mahadoo J, Hiebert LM, Jaques LB, Wright CJ.

Artery. 1980;7(5):438-47. No abstract available.

PMID:
7213028
23.

Anticoagulant activity and operative blood loss after intrapulmonary heparin.

Wright CJ, Mahadoo J, Jaques LB.

Br J Surg. 1979 Dec;66(12):844-7.

PMID:
509056
24.

Cellular control of heparin in blood.

Mahadoo J, Jaques LB.

Med Hypotheses. 1979 Aug;5(8):835-41.

PMID:
514121
25.

Heparin via the lung.

Wright CJ, Jaques LB.

Can J Surg. 1979 Jul;22(4):317-9.

PMID:
455159
26.

A novel method to separate the layers of the intestine.

Hiebert L, Jaques LB.

Can J Physiol Pharmacol. 1979 Jun;57(6):664-5.

PMID:
487273
27.

Heparins--anionic polyelectrolyte drugs.

Jaques LB.

Pharmacol Rev. 1979 Jun;31(2):99-166. Review. No abstract available.

PMID:
399524
28.

The department of physiology, University of Saskatchewan.

Jaques LB.

Physiologist. 1978 Oct;21(5):12-4. No abstract available.

PMID:
364501
29.

Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis.

Levy SW, Jaques LB.

Thromb Res. 1978 Sep;13(3):429-41. No abstract available.

PMID:
741437
30.

The nature of mucopolysaccharides.

Jaques LB.

Med Hypotheses. 1978 Mar-Apr;4(2):123-35. No abstract available.

PMID:
76982
31.

Addendum: the discovery of heparin.

Jaques LB.

Semin Thromb Hemost. 1978 Spring;4(4):350-3. No abstract available.

PMID:
675258
32.

The premises involved in the clinical use of heparin.

Jaques LB.

Semin Thromb Hemost. 1978 Spring;4(4):275-6. No abstract available.

PMID:
675257
33.

Vascular sequestration of heparin.

Mahadoo J, Heibert L, Jaques LB.

Thromb Res. 1978 Jan;12(1):79-90. No abstract available.

PMID:
644562
34.

A train difference in anticoagulant response to subcutaneous administration of heparin in mice.

Sue TK, Jaques LB, Yelland J.

Thromb Res. 1978 Jan;12(1):5-13. No abstract available.

PMID:
644560
35.

Pharmacodynamics and clinical effectiveness of heparin.

Jaques LB, Mahadoo J.

Semin Thromb Hemost. 1978 Spring;4(4):298-325. Review. No abstract available.

PMID:
353986
36.

The chemical and anticoagulant nature of heparin.

Jaques LB, McDuffie NM.

Semin Thromb Hemost. 1978 Spring;4(4):277-97. Review. No abstract available.

PMID:
150031
37.

Endogenous heparin.

Jaques LB.

Semin Thromb Hemost. 1978 Spring;4(4):326-49. No abstract available.

PMID:
97786
38.

Heparin and sulfated mucopolysaccharides--a micro system for quantitative differentiation and determination.

Jaques LB, Sue TK, McDuffie NM, Wice SM.

Can J Physiol Pharmacol. 1977 Oct;55(5):1179-89.

PMID:
72593
39.

The mast cell/heparin paradox.

Jaques LB, Mahadoo J, Riley JF.

Lancet. 1977 Feb 19;1(8008):411-3.

PMID:
65521
40.

Determination of heparin and related sulfated mucopolysaccharides.

Jaques LB.

Methods Biochem Anal. 1977;24:203-312. Review. No abstract available.

PMID:
144838
41.

Intrapulmonary heparin. A new procedure for anticoagulant therapy.

Jaques LB, Mahadoo J, Kavanagh LW.

Lancet. 1976 Nov 27;2(7996):1157-61.

PMID:
62993
42.

Susceptibility to experimental atherosclerosis: relation to mast cells and heparin.

Sue TK, Jaques LB.

Atherosclerosis. 1976 Oct;25(1):137-9.

PMID:
985595
44.

"Low-dose heparin"--significance of subcutaneous injection.

Jaques LB.

Thromb Res. 1976 Aug;9(2):205-8. No abstract available.

PMID:
968815
45.

Effects of acidity, cations and alcoholic fractionation on absorption of heparin from gastrointestinal tract.

Sue TK, Jaques LB, Yuen E.

Can J Physiol Pharmacol. 1976 Aug;54(4):613-7.

PMID:
10060
46.

The observation of heparin on endothelium after injection.

Hiebert LM, Jaques LB.

Thromb Res. 1976 Feb;8(2):195-204. No abstract available.

PMID:
1251350
47.

Letter: Identification of heparin in publications.

Jaques LB.

Thromb Res. 1976 Jan;8(1):115-8. No abstract available.

PMID:
1251338
48.

A new route of heparin administration--the lung.

Kavanagh LW, Jaques LB.

Arzneimittelforschung. 1976;26(3):389-92.

PMID:
989334
49.

Mobilization of chondroitin sulphate by nitrilotriacetic acid.

Jaques LB, Sue TK.

Toxicol Appl Pharmacol. 1975 Dec;34(3):521-4. No abstract available.

PMID:
128847
50.

What is "heparin"?

Jaques LB.

Adv Exp Med Biol. 1975;52:139-47. No abstract available.

PMID:
1124695

Supplemental Content

Loading ...
Support Center